Long-Term Effects of Opium Consumption Following Percutaneous Coronary Intervention: A 10-year Follow-Up Study
References
- Zanchin T, Raber L, Koskinas KC, Piccolo R, Juni P, Pilgrim T, et al. Preprocedural High-Sensitivity Cardiac Troponin T and Clinical Outcomes in Patients With Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Intervention. Circulation: Cardiovascular Interventions. 2016; 9(6). DOI: 10.1161/CIRCINTERVENTIONS.115.003202
- Roth C, Gangl C, Dalos D, Krenn L, Scherzer S, Gerken A, et al. Outcome after Elective Percutaneous Coronary Intervention Depends on Age in Patients with Stable Coronary Artery Disease – An Analysis of Relative Survival in a Multicenter Cohort and an OCT Substudy. PloS One. 2016; 11(4):
e0154025 . DOI: 10.1371/journal.pone.0154025 - Liu S, Song C, Zhao Y, Guan C, Zhu C, Feng L, et al. Impact of baseline thrombocytopenia on the long-term outcome of patients undergoing elective percutaneous coronary intervention: An analysis of 9,897 consecutive patients. Catheterization and Cardiovascular Interventions. 2019; 93(S1): 764–71. DOI: 10.1002/ccd.28030
- Amin-Esmaeili M, Rahimi-Movaghar A, Sharifi V, Hajebi A, Radgoodarzi R, Mojtabai R, et al. Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service utilization results from the Iranian Mental Health Survey. Addiction. 2016; 111(10): 1836–47. DOI: 10.1111/add.13453
- Masoudkabir F, Shafiee A, Heidari A, Mohammadi NSH, Tavakoli K, Jalali A, et al. Epidemiology of substance and opium use among adult residents of Tehran; a comprehensive report from Tehran cohort study (TeCS). BMC Psychiatry. 2024; 24(1): 132. DOI: 10.1186/s12888-024-05561-1
- Roayaei P, Aminorroaya A, Vasheghani-Farahani A, Oraii A, Sadeghian S, Poorhosseini H, et al. Opium and cardiovascular health: A devil or an angel? Indian Heart Journal. 2020; 72(6): 482–90. DOI: 10.1016/j.ihj.2020.10.003
- Sadeghian S, Darvish S, Davoodi G, Salarifar M, Mahmoodian M, Fallah N, et al. The association of opium with coronary artery disease. European Journal of Cardiovascular Prevention and Rehabilitation. 2007; 14(5): 715–7. DOI: 10.1097/HJR.0b013e328045c4e9
- Marmor M, Penn A, Widmer K, Levin RI, Maslansky R, et al. Coronary artery disease and opioid use. American Journal of Cardiology. 2004; 93(10): 1295–7. DOI: 10.1016/j.amjcard.2004.01.072
- Nakhaee S, Ghasemi S, Karimzadeh K, Zamani N, Alinejad-Mofrad S, Mehrpour O. The effects of opium on the cardiovascular system: a review of side effects, uses, and potential mechanisms. Substance Abuse Treatment, Prevention, and Policy. 2020; 15(1): 30. DOI: 10.1186/s13011-020-00272-8
- Bjornaas MA, Bekken AS, Ojlert A, Haldorsen T, Jacobsen D, Rostrup M, et al. A 20-year prospective study of mortality and causes of death among hospitalized opioid addicts in Oslo. BMC Psychiatry. 2008; 8(1): 8. DOI: 10.1186/1471-244X-8-8
- Abdiardekani A, Salimi M, Sarejloo S, Bazrafshan M, Askarinejad A, Salimi A, et al. Impacts of opium addiction on patterns of angiographic findings in patients with acute coronary syndrome. Scientific Reports. 2022; 12(1): 15209. DOI: 10.1038/s41598-022-19683-7
- Masoomi, M, Ramezani MA, Karimzadeh H. The relationship of opium addiction with coronary artery disease. Internation Journal of Preventive Medicine. 2010; 1(3): 182–6.
- Amirpour A, Kermani-Alghoraishi M, Sattar F, Roohafza H, Shahabi J, Zavar R, et al. Does Opioid Addiction Influence Clinical and Angiographic Outcomes in STEMI Patients Undergoing Emergency PCI? Adv Biomed Res. 2023; 12: 12. DOI: 10.4103/abr.abr_295_21
- Sharafi A, Pour Hosseini HR, Jalali A, Salarifar M, Nematipour E, Shojanasab M, et al. Opium consumption and mid-term outcome of percutaneous coronary intervention in men. J Tehran Heart Cent. 2014; 9(3): 115–9.
- Poorhosseini H, Abbasi SH. The Tehran Heart Center. European Heart Journal. 2018; 39(29): 2695–6. DOI: 10.1093/eurheartj/ehy369
- Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Statistics in Medicine. 2015; 34(28): 3661–79. DOI: 10.1002/sim.6607
- Xu S, Ross C, Raebel MA, Shetterly S, Blanchette C, Smith D. Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals. Value Health. 2010; 13(2): 273–7. DOI: 10.1111/j.1524-4733.2009.00671.x
- Khademi H, Malekzadeh R, Pourshams A, Jafari E, Salahi R, Semnani S, et al. Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50,000 adults in Iran. BMJ. 2012; 344:
e2502 . DOI: 10.1136/bmj.e2502 - Setoguchi S, Cabral H, Jick S. Opioid use for noncancer pain and risk of myocardial infarction amongst adults. Journal of Internal Medicine. 2013; 273(5): 511–26. DOI: 10.1111/joim.12035
- Davoodi G, Sadeghian S, Akhondzadeh S, Darvish S, Alidoosti M, Amirzadegan A. Comparison of specifications, short term outcome and prognosis of acute myocardial infarction in opium dependent patients and nondependents. The Journal of Tehran University Heart Center. 2006; 1(1): 48–53.
- Rostamzadeh A, Khademvatani K. COMPARISON OF MYOCARDIAL INFARCTION OUTCOME IN OPIUM DEPENDENT AND NON-DEPENDENT PATIENTS. Studies in Medical Sciences. 2016; 27(3): 208–14.
- Dehghani F, Masoomi M, Haghdoost AA. Relation of opium addiction with the severity and extension of myocardial infarction and its related mortality. Addict Health. 2013; 5(1–2): 35–42.
- Okubo S, Tanabe Y, Takeda K, Kitayama M, Kanemitsu S, Kukreja RC, et al. Ischemic preconditioning and morphine attenuate myocardial apoptosis and infarction after ischemia-reperfusion in rabbits: role of delta-opioid receptor. American Journal of Physiology-Heart and Circulatory Physiology. 2004; 287(4): H1786–91. DOI: 10.1152/ajpheart.01143.2003
- Hasandokht T, Salari A, Pour SS, Tirani HD, Shad B, Rajabi E. Does opium have benefit for coronary artery disease? A systematic review. Cardiovascular medicine. 2018; 7(2): 51–8. DOI: 10.4103/rcm.rcm_12_17
- Masoudkabir F, Yavari N, Pashang M, Sadeghian S, Jalali A, Poorhosseini H, et al. Effect of persistent opium consumption after surgery on the long-term outcomes of surgical revascularisation. Eur J Prev Cardiol. 2020; 27(18): 1996–2003. DOI: 10.1177/2047487320932010
- Khalili P, Ayoobi F, Mohamadi M, Jamalizadeh A, La Vecchia C, Esmaeili-Nadimi A. Effect of opium consumption on cardiovascular diseases – a cross- sectional study based on data of Rafsanjan cohort study. BMC Cardiovascular Disorders. 2021; 21(1): 2. DOI: 10.1186/s12872-020-01788-4
- Azdaki N, Zardast M, Anani-Sarab G, Abdorrazaghnaejad H, Ghasemian MR, Saburi A. Comparison between Homocysteine, Fibrinogen, PT, PTT, INR and CRP in Male Smokers with/without Addiction to Opium. Addict Health. 2017; 9(1): 17–23.
- Shahouzehi B, Shokoohi M, Najafipour H. The effect of opium addiction on serum adiponectin and leptin levels in male subjects: a case control study from Kerman Coronary Artery Disease Risk Factors Study (KERCADRS). EXCLI J. 2013; 12: 916–23.
- Asadikaram G, Igder S, Jamali Z, Shahrokhi N, Najafipour H, Shokoohi M, et al. Effects of Different Concentrations of Opium on the Secretion of Interleukin-6, Interferon-gamma and Transforming Growth Factor Beta Cytokines from Jurkat cells. Addict Health. 2015; 7(1–2): 47–53.
- Lashkarizadeh MR, Garshasbi M, Shabani M, Dabiri S, Hadavi H, Manafi-Anari H. Impact of Opium Addiction on Levels of Pro- and Anti-inflammatory Cytokines after Surgery. Addict Health. 2016; 8(1): 9–15.
- Kubica, J, Adamski P, Ostrowska M, Sikora J, Kubica JM, Sroka WD, et al. Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial. European Heart Journal. 2016; 37(3): 245–52. DOI: 10.1093/eurheartj/ehv547
- Forood A, Malekpour-Afshar R, Sarnevesht J. Effect of opium addiction on aspirin resistance in stable angina pectoris. Addict Health. 2014; 6(1–2): 7–13.
- Roohafza H, Talaei M, Sadeghi M, Haghani P, Shokouh P, Sarrafzadegan N. Opium decreases the age at myocardial infarction and sudden cardiac death: a long- and short-term outcome evaluation. Archives of Iranian Medicine. 2013; 16(3): 154–60.
- Najafipour H, Masoomi M, Shahesmaeili A, Haghdoost AA, Afshari M, Nasri HR, et al. Effects of opium consumption on coronary artery disease risk factors and oral health: Results of Kerman Coronary Artery Disease Risk factors Study a population-based survey on 5900 subjects aged 15–75 years. International Journal of Preventive Medicine. 2015; 6:42. DOI: 10.4103/2008-7802.157470
- Sadeghian S, Graili P, Salarifar M, Karimi AA, Darvish S, Abbasi SH. Opium consumption in men and diabetes mellitus in women are the most important risk factors of premature coronary artery disease in Iran. International Journal of Cardiology. 2010; 141(1): 116–8. DOI: 10.1016/j.ijcard.2008.11.063
- Nalini M, Oranuba E, Poustchi H, Sepanlou SG, Pourshams A, Khoshnia M, et al. Causes of premature death and their associated risk factors in the Golestan Cohort Study, Iran. BMJ Open. 2018; 8(7):
e021479 . DOI: 10.1136/bmjopen-2018-021479
DOI: https://doi.org/10.5334/gh.1315 | Journal eISSN: 2211-8179
Language: English
Submitted on: Jun 14, 2023
Accepted on: Feb 27, 2024
Published on: Apr 24, 2024
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2024 Ali Izadi Amoli, Alireza Oraii, Faezeh Aghajani, Mana Jameie, Zahra Lotfi, Arash Jalali, Akbar Shafiee, Mohammad Sadeq Najafi, Masoumeh Lotfi-Tokaldany, Seyedeh Hamideh Mortazavi, Mojgan Ghavami, Ignacio J. Amat-Santos, Mohammad Hadi Mansouri, Hassan Aghajani, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.